Tres Vision Group is a leading health care startup that focuses on providing comprehensive medical and surgical eye care services. Since its establishment in 1985, the company has been dedicated to diagnosing and treating various vision disorders, including cataracts, glaucoma, diabetic retinopathy, corneal conditions, macular degeneration, and dry eyes.
The company's slogan - "'Fixing your eye sight' so you can fix your eyes on what matters most" encapsulates its mission to heal and, whenever possible, cure or fix patients’ eyes, enabling them to focus on what truly matters. Tres Vision Group follows a patient-centric practice philosophy and integrates the latest state-of-the-art advances in eye care, ensuring the highest quality of service and treatment. The startup's commitment to excellence is further reinforced by its compassionate staff and skilled medical team.
Tres Vision Group operates through a cooperative care model, where a team of medical experts collaborates to enhance patients’ outcomes and experiences. The inherent trust that each patient bestows upon the company, considering sight as their most precious gift, underscores the immense responsibility and commitment with which Tres Vision Group approaches its operations.
As of the latest available information, there is no specific data regarding the headquarter location or the last investment and its associated investors. However, given the critical nature of its services and its long-standing presence in the industry, Tres Vision Group presents an intriguing opportunity for potential investors in the health care sector. With its clear focus on patient well-being and cutting-edge treatment methodologies, the company stands as a compelling prospect in the ever-evolving landscape of medical innovation and care.